Xenografts in zebrafish embryos as a rapid functional assay for breast cancer stem-like cell identification

Cell Cycle

Volumn 10, Issue 21, 2011, Pages 3751-3757

  Eguiara, Arrate ^a   Holgado, Olaia ^b   Beloqui, Izaskun ^a   Abalde, Leire ^a   Sanchez, Yolanda ^a   Callol, Carles ^b   Martin, Angel G ^a  

^a Biomedical Research and Technological Development Institute   (Spain)

^b Biobide SL   (Spain)

Author keywords

Breast cancer; Cancer stem cells; Curcumin; Mammosphere; Xenograft; Zebrafish

Indexed keywords

ALDEHYDE DEHYDROGENASE; CURCUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CANCER STEM CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL VIABILITY; DIET SUPPLEMENTATION; EMBRYO; FERTILIZATION; GRAFT RECIPIENT; IN VIVO STUDY; NONHUMAN; TUMOR XENOGRAFT; ZEBRA FISH;

DANIO RERIO;

EID: 80655129539     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.21.17921     Document Type: Article

References (41)

1. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009; 8:806-23; PMID:19794444; DOI:10.1038/nrd2137.
2. Kemper K, Grandela C, Medema JP. Molecular identification and targeting of colorectal cancer stem cells. Oncotarget 2010; 1:387-95; PMID:21311095.
3. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009; 15:907-13; PMID:19648928; DOI:10.1038/nm.2000.
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983-8; PMID:12629218; DOI:10.1073/pnas.0530291100.
5. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65:5506-11; PMID:15994920; DOI:10.1158/0008-5472.CAN-05-0626.
6. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1:555-67; PMID:18371393; DOI:10.1016/j.stem.2007.08.014.
7. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008; 100:672-9; PMID:18445819; DOI:10.1093/jnci/djn123.
8. Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 2009; 15:4234-41.
9. Curtin JC, Lorenzi MV. Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 2010; 1:563-77; PMID:21317452.
10. Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, Anderson NG, et al. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 2007; 99:616-27; PMID:17440163; DOI:10.1093/jnci/djk133.
11. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17:1253-70; PMID:12756227; DOI:10.1101/gad.1061803.
12. Ao A, Morrison BJ, Wang H, Lopez JA, Reynolds BA, Lu J. Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments. PLoS ONE 2011; 6:18810; PMID:21533195; DOI:10.1371/journal.pone. 0018810.
13. Heuser M, Humphries RK. Biologic and experimental variation of measured cancer stem cells. Cell Cycle 2010; 9:909-12; PMID:20348851; DOI:10.4161/cc.9.5.10852.
14. Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005; 4:35-44; PMID:15688071; DOI:10.1038/nrd1606.
15. Lee LM, Seftor EA, Bonde G, Cornell RA, Hendrix MJ. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 2005; 233:1560-70; PMID:15968639; DOI:10.1002/dvdy.20471.
16. Haldi M, Ton C, Seng WL, McGrath P. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 2006; 9:139-51; PMID:17051341; DOI:10.1007/s10456-006-9040-2.
17. Westerfield M. The zebrafish book: a guide for the laboratory use of zebrafish. Eugene: The University of Oregon Press 1993.
18. Traver D, Herbomel P, Patton EE, Murphey RD, Yoder JA, Litman GW, et al. The zebrafish as a model organism to study development of the immune system. Adv Immunol 2003; 81:253-330; PMID:14711058; DOI:10.1016/S0065-2776(03)81007-6.
19. Detrich HW, 3rd, Westerfield M, Zon LI. Overview of the Zebrafish system. Methods Cell Biol 1999; 59:3-10; PMID:9891351; DOI:10.1016/S0091-679X(08)61816- 6.
20. Liu S, Dontu G, Wicha MS. Mammary stem cells, self-renewal pathways and carcinogenesis. Breast Cancer Res 2005; 7:86-95; PMID:15987436; DOI:10.1186/bcr1021.
21. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, et al. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 2011; PMID: 21822303; DOI:10.1038/onc.2011.338.
22. Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, Ginestier C, et al. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 2010; 122:777-85; PMID:19898931; DOI:10.1007/s10549-009-0612-x.
23. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 2008; 456:593-8; PMID:19052619; DOI:10.1038/nature07567.
24. Park SW, Davison JM, Rhee J, Hruban RH, Maitra A, Leach SD. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 2008; 134:2080-90; PMID:18549880; DOI:10.1053/j.gastro.2008.02.084.
25. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CD, et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci USA 2005; 102:407-12; PMID:15630097; DOI:10.1073/pnas. 0406252102.
26. Haramis AP, Hurlstone A, van der Velden Y, Begthel H, van den Born M, Offerhaus GJ, et al. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep 2006; 7:444-9; PMID:16439994.
27. Guo L, Chua J, Vijayakumar D, Lee KC, Lim K, Eng H, et al. Detection of the 113p53 protein isoform: a p53-induced protein that feeds back on the p53 pathway to modulate the p53 response in zebrafish. Cell Cycle 2010; 9:1998-2007; PMID:20505327; DOI:10.4161/cc.9.10.11732.
28. White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008; 2:183-9; PMID:18371439; DOI:10.1016/j.stem.2007.11.002.
29. Nicoli S, Ribatti D, Cotelli F, Presta M. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res 2007; 67:2927-31; PMID:17409396; DOI:10.1158/0008-5472.CAN-06-4268.
30. Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk A, et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009; 9:128; PMID:19400945; DOI:10.1186/1471-2407-9-128.
31. Geiger GA, Fu W, Kao GD. Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system. Cancer Res 2008; 68:3396-404; PMID:18451167; DOI:10.1158/0008-5472.CAN-07-6396.
32. Langenau DM, Keefe MD, Storer NY, Guyon JR, Kutok JL, Le X, et al. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 2007; 21:1382-95; PMID:17510286; DOI:10.1101/gad.1545007.
33. Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci USA 2007; 104:17406-11; PMID:17954920; DOI:10.1073/pnas. 0703446104.
34. Zhou J, Zhang H, Gu P, Bai J, Margolick JB, Zhang Y. NFkappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res Treat 2008; 111:419-27.
35. Cioce M, Gherardi S, Viglietto G, Strano S, Blandino G, Muti P, et al. Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. Cell Cycle 2010; 9:2878-87; PMID:20581442; DOI:10.4161/cc.9.14.12371.
36. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 2008; 10:25; PMID:18366788; DOI:10.1186/bcr1982.
37. Keller PJ, Lin AF, Arendt LM, Klebba I, Jones AD, Rudnick JA, et al. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res 2010; 12:87; PMID:20964822; DOI:10.1186/bcr2755.
38. Blick T, Hugo H, Widodo E, Waltham M, Pinto C, Mani SA, et al. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia 2010; 15:235-52; PMID:20521089; DOI:10.1007/s10911-010-9175-z.
39. Rouhi P, Lee SL, Cao Z, Hedlund EM, Jensen LD, Cao Y. Pathological angiogenesis facilitates tumor cell dissemination and metastasis. Cell Cycle 2010; 9:913-7; PMID:20160500; DOI:10.4161/cc.9.5.10853.
40. Creighton CJ, Chang JC, Rosen JM. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 2010; 15:253-60; PMID:20354771; DOI:10.1007/s10911-010-9173-1.
41. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704-15; PMID:18485877; DOI:10.1016/j.cell.2008.03.027.